SANCTURA XR
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
Aug 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SANCTURA XR is an extended-release oral capsule formulation approved in 2007 as a small-molecule antispasmodic agent. The product treats overactive bladder symptoms by acting on muscarinic receptors in the urinary tract. It is indicated for patients experiencing urge incontinence, urgency, and urinary frequency.
LOE Approaching
As LOE approaches, brand team size is likely contracting; positions shifting toward lifecycle management and generic transition planning rather than growth-focused expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Started Mar 2010
322 enrolled
Overactive Bladder
Career Relevance
Working on SANCTURA XR offers limited growth trajectory and minimal job creation as the product approaches loss of exclusivity. Career advancement typically involves transitioning to newer pipeline assets or shifting to generic/lifecycle management expertise.
Brand Manager
Worked on SANCTURA XR at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.